Harnessing SeN to develop novel fluorescent probes for visualizing the variation of endogenous hypobromous acid (HOBr) during the administration of an immunotherapeutic agent.
Harnessing SeN to develop novel fluorescent probes for visualizing the variation of endogenous hypobromous acid (HOBr) during the administration of an immunotherapeutic agent.
复制标题
DOI:
10.1039/d1cc04832e
复制
发表时间:
2021-11
影响因子:
4.9
通讯作者:
J. Zhang;Kaiqiang Liu;Jingwen Li;Yingying Xie;Yong Li;Xu Wang;Xilei Xie;Xiaoyun Jiao;
中科院分区:
文献类型:
--
作者:
J. Zhang;Kaiqiang Liu;Jingwen Li;Yingying Xie;Yong Li;Xu Wang;Xilei Xie;Xiaoyun Jiao;
By means of the formation of SeN, the ABT-Se and NDI-Se were developed to detect and visualize endogenous hypobromous acid (HOBr) in live cells. Specifically, the upregulation of HOBr was monitored by NDI-Se during the administration of an immunotherapeutic agent.